Alpine Immune Sciences, Inc. (ALPN) Social Stream
ALPINE IMMUNE SCIENCES INC (ALPN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ALPINE IMMUNE SCIENCES INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 20 months, ALPN's average price target has gone down $5.
ALPN reports an average of 122.97% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ALPN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ALPN's average broker recommendation rating improved by 0 over the prior 48 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ALPINE IMMUNE SCIENCES INC's number of analysts covering the stock is higher than 168.94% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, ALPINE IMMUNE SCIENCES INC's average analyst price target is higher than 196.22% of them.
- To contextualize these metrics, consider that out of all US stocks, ALPINE IMMUNE SCIENCES INC's variance in analysts' estimates is lower than -320.9% of them.
- ALPINE IMMUNE SCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 305.96% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ALPINE IMMUNE SCIENCES INC are VKTX, COLL, and RDHL.
View All Top Stocks by Price Target
Is ALPN a Buy, Hold or Sell? See the POWR Ratings now!